CAR (chimeric antigen receptor) T-cell illustration.
March 28, 2024

Cell-Easy Signs Groundbreaking Manufacturing Contract, Paving the Way for Local Hospitals to Offer Next-Generation CAR-T Therapy.

Cell-Easy Signs Groundbreaking Manufacturing Contract, Paving the Way for Local Hospitals to Offer Next-Generation CAR-T Therapy Toulouse, France, march 26, 2024 –  This agreement with a pioneer European C&G company will soon enable the initiation of new clinical trials in South of France based on innovative CAR-T cell treatments  

+ Read More

your CDMO Partner for Cell Therapy

Keep in touch
Linkedin

Cell-Easy

4 Bis avenue Hubert Curien

31100 Toulouse,

FRANCE

Science-driven CDMO specialized in Cell Therapy, Cell-Easy offers customized process development, GMP manufacturing and analytical services for immune cells and adult stem cells in Immuno-oncology and Regenerative Medicine fields.

Privay Policy